US Stock MarketDetailed Quotes

LENZ LENZ Therapeutics

Watchlist
  • 22.480
  • -0.100-0.44%
Trading Mar 11 12:07 ET
618.22MMarket Cap-5.35P/E (TTM)

LENZ Therapeutics Key Stats

LENZ Therapeutics Q4 2024 Estimates Date

Currency:USDMar 19, 2025

Estimate YoY
Revenue
0
--
EPS
-0.41
--
Buy

Feb 28, 2025

LENZ Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
Mar 19, 20252024/Q4-- / 0.000--
Nov 6, 20242024/Q30.000 / 0.000--
Aug 14, 20242024/Q20.000 / 0.000--
May 8, 20242024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
Mar 19, 20252024/Q4-- / 0.000--
Nov 6, 20242024/Q30.000 / 0.000--
Aug 14, 20242024/Q20.000 / 0.000--
May 8, 20242024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

LENZ Therapeutics Earnings Reports

Read more

Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Feb 28, 2025

Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data